Alice GottliebSteering Committee Member

Alice Gottlieb is a Clinical Professor of Dermatology at the Icahn School Of Medicine at Mount Sinai, Union Square, New York, US. She is triple-boarded in dermatology, rheumatology, and internal medicine and has a PhD in immunology From from The Rockefeller University. 

Professor Gottlieb founded the Dermatology Residency Program at Tufts Medical Center and the Dermatology Division at UMDNJ-Robert Wood Johnson Medical School. She is also the founder and president of the IDEOM (International Dermatology Outcomes Measures) group. Throughout her career, Gottlieb has focused on the pathogenesis and treatment of psoriasis and psoriatic arthritis,  and was the first to publish a study that demonstrated the efficacy of TNF blockers as monotherapy in psoriasis, leading to TNF blockers being approved for use and resulting in significant changes to the way psoriasis is treated.